← Back to Search

Other

Tailored Advice Tool for Weight Loss

N/A
Waitlist Available
Led By Brooke Nezami, PhD, MA
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial tests if a new tool can help people lose weight, by giving tailored advice based on reinforcement learning.

Who is the study for?
This trial is for adults aged 18-55 with a BMI of 25-40 who are not meeting US physical activity guidelines, can speak and write English, have no major health issues that limit exercise, and own a smartphone. Excluded are those on weight loss meds, pregnant or planning pregnancy soon, with certain medical conditions like diabetes requiring insulin treatment or recent cancer treatment.Check my eligibility
What is being tested?
The ADAPT study is testing the AdaptRL tool over 12 weeks to see if it helps people lose weight by suggesting personalized behavior change techniques. It builds on an existing approach that adjusts support based on how individuals respond to different contexts in real-time.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. There might also be psychological impacts from changing diet and activity habits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility (success of using the AdaptRL Tool)
Self-monitoring adherence
Study engagement
Secondary outcome measures
Achievement of active minutes goal
Achievement of active minutes goal percent of person-days
Achievement of calorie goal (at or under goal)
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ADAPT interventionExperimental Treatment1 Intervention
Participants will receive a smart scale and a physical activity tracker and will have three daily goals: weigh daily, a daily personalized active minutes goal, and a daily calorie goal. For 12 weeks, participants will receive 0-3 text messages per day about their behaviors and progress towards their goals which they will be able to rate (like/dislike), along with weekly personalized feedback, progress graphs, and lessons and resources available on the website.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADAPT
2015
N/A
~570

Find a Location

Who is running the clinical trial?

RTI InternationalOTHER
190 Previous Clinical Trials
876,331 Total Patients Enrolled
3 Trials studying Obesity
1,915 Patients Enrolled for Obesity
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
353 Previous Clinical Trials
90,393 Total Patients Enrolled
2 Trials studying Obesity
118 Patients Enrolled for Obesity
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,344 Total Patients Enrolled
48 Trials studying Obesity
31,468 Patients Enrolled for Obesity

Media Library

ADAPT (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05751993 — N/A
Obesity Research Study Groups: ADAPT intervention
Obesity Clinical Trial 2023: ADAPT Highlights & Side Effects. Trial Name: NCT05751993 — N/A
ADAPT (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05751993 — N/A
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top